# AstraZeneca invests €65M in Alexion Irish plants in Dublin and Athlone

AstraZeneca is investing an additional €65 million to upgrade Alexion's drug substance production facilities in Dublin and Athlone, Ireland, including new machinery and a production and science technology lab.

- Type: Expansion
- Announced: 2022-06-27
- Where: Dublin and Athlone, Ireland, Ireland
- Value: $68.7M (65.0M EUR)
- Status: announced
- Products: drug substances, biologic medication substances
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [AstraZeneca](https://endata.com/companies/35467.md)
- [Alexion Pharmaceuticals, Inc.](https://endata.com/companies/63721.md) (target)

## Sources

- [worldpharmatoday.com](https://www.worldpharmatoday.com/news/alexion-irish-factory-gets-a-68-7m-upgrade-from-astrazeneca/), 2022-06-27: "The company now claims to be investing an additional 65 million euros ($68.7 million) in the location and an Alexion plant in Ireland’s Athlone, 120 kilometres to the west."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.